Loading clinical trials...
Loading clinical trials...
This is a Phase Ib, open-label, two-stage study with two active regimens in each stage designed to evaluate the safety and tolerability of combination treatment with atezolizumab, trastuzumab, and per...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Hoffmann-La Roche
NCT06625775 · Solid Tumor, Adult, Metastatic Breast Cancer, and more
NCT05800275 · Leptomeningeal Metastasis, Leptomeningeal Disease, and more
NCT06551116 · HER2-positive Metastatic Breast Cancer
NCT05362760 · Hormone Receptor-positive Metastatic Breast Cancer, HER2-negative Metastatic Breast Cancer
NCT03417544 · HER2-positive Metastatic Breast Cancer, Central Nervous System Metastases
University of Alabama at Birmingham
Birmingham, Alabama
University of Arkansas for Medical Sciences; Winthrop Rockefeller Cancer Institute
Little Rock, Arkansas
Joliet oncology hematology associates
Joliet, Illinois
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions